These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

130 related articles for article (PubMed ID: 4054715)

  • 61. VP-16, cyclophosphamide, adriamycin and cis-platinum (V:CAP-I) in patients with metastatic adenocarcinoma of the lung.
    Eagan RT; Creagan ET; Ingle JN; Rubin J; Frytak S; Kvols LK; Fleming TR
    Tumori; 1979 Feb; 65(1):105-9. PubMed ID: 442215
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Cisplatin and etoposide in chemotherapy-refractory advanced breast cancer.
    Giaccone G; Donadio M; Ferrati P; Calciati A
    Tumori; 1988 Apr; 74(2):191-3. PubMed ID: 3368973
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Cis-dichlorodiammineplatinum (II), VP 16-213, and prednisone (DVP regimen) in the treatment of pretreated advanced malignant lymphomas.
    Fosser VP; Salvagno L; Segati R; Pappagallo GL; Ferrazzi E; Sileni VC; Fiorentino MV
    Tumori; 1982 Dec; 68(6):515-8. PubMed ID: 6762740
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Cisplatin plus etoposide as second-line treatment in advanced ovarian carcinoma.
    De Lena M; Lorusso V; Romito S
    Cancer Treat Rep; 1986 Jul; 70(7):893-5. PubMed ID: 3719581
    [TBL] [Abstract][Full Text] [Related]  

  • 65. 4'-epi-doxorubicin in combination with cisplatin in advanced ovarian cancer.
    Martoni A; Tomasi L; Farabegoli G; Fruet F; Pannuti F
    Cancer Treat Rep; 1984 Nov; 68(11):1391-3. PubMed ID: 6594196
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Oral etoposide (VP16) in platinum-resistant epithelial ovarian cancer (EOC).
    Alici S; Saip P; Eralp Y; Aydiner A; Topuz E
    Am J Clin Oncol; 2003 Aug; 26(4):358-62. PubMed ID: 12902885
    [TBL] [Abstract][Full Text] [Related]  

  • 67. [Intraperitoneal administration of high doses of cisplatin in advanced ovarian carcinoma].
    Ptácková B; Kopecný J; Zatocil P; Anton M
    Cesk Gynekol; 1989 Mar; 54(2):106-9. PubMed ID: 2731237
    [TBL] [Abstract][Full Text] [Related]  

  • 68. A phase II evaluation of menogaril in cisplatin-refractory advanced ovarian carcinoma. A collaborative trial of the North Central Cancer Treatment Group and the Mayo Clinic.
    Long HJ; Laurie JA; Wieand HS; Edmonson JH; Levitt R; Krook JE; Abu-Ghazaleh S
    Cancer; 1991 Aug; 68(4):730-2. PubMed ID: 1830238
    [TBL] [Abstract][Full Text] [Related]  

  • 69. [A phase II trial of etoposide (VP-16) administered intravenously in the treatment of malignant lymphoma and acute leukemia].
    Moriyama Y; Shibata A; Maekawa I; Yoshida Y; Miura A; Wakui A; Kariyone S; Maekawa T; Miura Y; Abe T
    Rinsho Ketsueki; 1985 Nov; 26(11):1774-84. PubMed ID: 3835288
    [No Abstract]   [Full Text] [Related]  

  • 70. Phase II study of etoposide for carcinoma of the prostate.
    Walther PJ; Williams SD; Troner M; Greco FA; Birch R; Einhorn LH
    Cancer Treat Rep; 1986 Jun; 70(6):771-2. PubMed ID: 3524825
    [TBL] [Abstract][Full Text] [Related]  

  • 71. A phase II trial of gallium nitrate (NSC #15200) in previously treated ovarian carcinoma. A Gynecologic Oncology Group Study.
    Malfetano JH; Blessing JA; Adelson MD
    Am J Clin Oncol; 1991 Aug; 14(4):349-51. PubMed ID: 1862766
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Oral etoposide is active against platinum-resistant epithelial ovarian cancer.
    Hoskins PJ; Swenerton KD
    J Clin Oncol; 1994 Jan; 12(1):60-3. PubMed ID: 8270985
    [TBL] [Abstract][Full Text] [Related]  

  • 73. A phase II trial of intraperitoneal cisplatin and etoposide as salvage treatment for minimal residual ovarian carcinoma.
    Kirmani S; Lucas WE; Kim S; Goel R; McVey L; Morris J; Howell SB
    J Clin Oncol; 1991 Apr; 9(4):649-57. PubMed ID: 2066761
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Etoposide and cisplatin salvage chemotherapy for small cell lung cancer.
    Lopez JA; Mann J; Grapski RT; Nassif E; Vannicola P; Krikorian JG; Finkel H
    Cancer Treat Rep; 1985 Apr; 69(4):369-71. PubMed ID: 2986833
    [TBL] [Abstract][Full Text] [Related]  

  • 75. [Clinical trial of cisplatin in the treatment of ovarian carcinoma].
    Yoshizawa H; Kanazawa K; Takeuchi S; Okamura Y; Goto S; Kajiwara T
    Gan To Kagaku Ryoho; 1982 May; 9(5):822-30. PubMed ID: 6764112
    [TBL] [Abstract][Full Text] [Related]  

  • 76. A phase II study of mitozantrone in advanced carcinoma of the ovary.
    Coleman R; Clarke J; Gore M; Wiltshaw E; Slevin M; Harper P
    Cancer Chemother Pharmacol; 1989; 24(3):200-2. PubMed ID: 2736711
    [TBL] [Abstract][Full Text] [Related]  

  • 77. [A phase II study of etoposide (NK 171) in small cell lung cancer--comparison of results between intravenous administration and oral administration].
    Furuse K
    Gan To Kagaku Ryoho; 1985 Dec; 12(12):2352-7. PubMed ID: 3000299
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Exploring the use of chronic low-dose oral etoposide in ovarian cancer: is there a role for this "new drug" in the management of platinum-refractory disease?
    Markman M; Hakes T; Reichman B; Barakat R; Curtin J; Jones W; Lewis JL; Rubin S; Almadrones L; Hoskins W
    Semin Oncol; 1992 Dec; 19(6 Suppl 14):25-7. PubMed ID: 1488652
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Phase II trial of etoposide in advanced prostate cancer.
    Trump DL; Loprinzi CL
    Cancer Treat Rep; 1984 Sep; 68(9):1195-6. PubMed ID: 6478456
    [No Abstract]   [Full Text] [Related]  

  • 80. VP-16 alone and in combination with cisplatin in previously treated patients with small cell lung cancer.
    Evans WK; Feld R; Osoba D; Shepherd FA; Dill J; Deboer G
    Cancer; 1984 Apr; 53(7):1461-6. PubMed ID: 6321006
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.